26 June 2023>: Clinical Research
Glasgow Coma Scale as an Indicator of Patient Prognosis: A Retrospective Study of 257 Patients with Heatstroke from 3 Medical Centers in Guangdong, China
HuaiSheng Chen 1CE , Ronglin Chen 2B , Xinghui Wu 3B , Jing Qian 4B , Xuezhi Shi 3B , Lulu Wan 5BD , Wang Fanfan 4F , Huasheng Tong 3AG*DOI: 10.12659/MSM.939118
Med Sci Monit 2023; 29:e939118
Table 1 Baseline demographic characteristics of non-surviving and surviving patients with heatstroke.
Non-survival group | Survival group | p-value | |
---|---|---|---|
Cases | 27 | 230 | |
Age (y, M±SD) | 32.89±16.97 | 33.45±14.34 | 0.85 |
Gender | 0.86 | ||
male (cases, %) | 26 (10.12%) | 220 (85.60%) | |
female (cases, %) | 1 (0.39%) | 10 (3.89%) | |
Coma (cases, %) | 24 (88.89%) | 51 (22.17%) | |
GCS score (M±SD) | 5.67±3.55 | 12.35±4.05 | |
APACHE II score (M±SD) | 25.00±10.14 | 9.26±7.24 | |
SOFA score (M±SD) | 9.63±1.51 | 3.84±3.06 | |
HR (beat/min, M±SD) | 125.33±29.26 | 88.48±25.64 | |
RR (breath/min, M±SD) | 23.28±7.32 | 20.96±3.33 | 0.006 |
MAP (mmHg, M±SD) | 79.49±21.55 | 87.73±14.13 | 0.009 |
T (°C, M±SD) | 40.87±1.19 | 39.89±1.46 | 0.003 |
T (°C, M±SD) | 38.64±1.60 | 37.30±1.25 | |
Laboratory indexes | |||
Leukocyte(×10/L,M±SD) | 12.61±5.23 | 12.03±5.06 | 0.58 |
HCT (%,M±SD) | 33.82±13.93 | 41.51±9.02 | |
PLT (×10/L, M±SD) | 89.15±70.76 | 187.22±89.10 | |
TBIL (umol/L, M±SD) | 83.01±100.87 | 26.05±34.19 | |
ALB (g/L, M±SD) | 36.72±6.20 | 43.16±6.90 | |
SCr (umol/L, M±SD) | 215.18±81.03 | 146.60±85.65 | |
CK-MB (ng/ml, M±SD) | 162.02±190.11 | 45.00±95.89 | |
GCS – Glasgow Coma Scale; APACHE II score – Acute Physiology and Chronic Health Evaluation II score; SOFA score – Sequential Organ Failure Assessment Score; HR – heart rate; RR – respiratory rate; MAP – mean arterial pressure; T – the max body temperature; T – the body temperature at admission; HCT – hematocrit; PLT – platelet; TBIL – total bilirubin; ALB – albumin; SCr – serum creatinine; CK-MB – creatine kinase isoenzyme. |